Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A note on the analysis of titration studies.

C Chuang-Stein¹, W J Shih

¹Research Support Biostatistics Unit, Upjohn Company, Kalamazoo, MI 49001.

Statistics in Medicine

|March 1, 1991

Summary

This study introduces a new method for evaluating interventions using binary data, even with non-random dropouts. The procedure penalizes efficacy parameters based on dropouts, improving analysis for dose-response relationships and phase III studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Selection bias for treatments with positive Phase 2 results.

Pharmaceutical statistics·2020

Same author

Recent Developments in the Prevention and Treatment of Missing Data.

Therapeutic innovation & regulatory science·2018

Same author

Erratum to: Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015

Same author

Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2014

Same author

Discounting phase 2 results when planning phase 3 clinical trials.

Pharmaceutical statistics·2012

Same author

A longitudinal study of the impact of interviews on medical school admissions in Taiwan.

Evaluation & the health professions·2010

Area of Science:

Biostatistics
Clinical Trial Methodology
Pharmacometrics

Background:

Dropout analysis in clinical trials is crucial for accurate intervention evaluation.
Existing methods often assume random dropouts, limiting their applicability.
Titration studies with binary data present unique challenges for dropout incorporation.

Purpose of the Study:

To develop a robust method for incorporating all dropout types in intervention evaluation.
To address the limitations of existing methods that assume random dropouts.
To provide a flexible procedure applicable to binary data from titration studies.

Main Methods:

A novel procedure for evaluating interventions with binary data from titration studies.
Incorporation of all dropout types, without assuming randomness.
A built-in penalty factor in estimation for efficacy-related dropouts.
A method for estimating variances associated with the efficacy estimates.

Main Results:

The proposed method effectively incorporates all dropout types, regardless of their randomness.
A penalty factor is integrated into the estimation process to account for efficacy-related dropouts.
A method for estimating variances of the efficacy estimates is presented.
The procedure demonstrates utility in exploring dose-response relationships.

Conclusions:

The developed method offers a more comprehensive approach to intervention evaluation in the presence of diverse dropout patterns.
This procedure is valuable for analyzing titration studies and informing decisions for phase III clinical trials.
The application to a phase III antihypertension study illustrates the practical utility of the proposed methodology.

Related Experiment Videos